Category list : Anti-asthmatic agents
Sort by: Newest first Oldest first A-Z Z-A
-
Inhaled steroids suppress growth in children, conclude Cochrane reviewers Subscription
Reviews of data about the effects on growth of corticosteroid inhalers in asthmatic children have reinforced guidance that the lowest effective dose should be given.
-
Primum non nocere Subscription
We welcome the comments from Stuart Hill providing a counter-argument to the concerns initially raised by the UK Clinical Pharmacy Association Respiratory Group about Relvar Ellipta.
-
Dosing and compliance Subscription
There appears to be a contradiction in the opening and closing paragraphs of Stuart Hill’s letter. In the first paragraph he criticises concerns over comparative potencies of corticosteroids as being “theoretical” and not evidence based but, in his final sentence, he suggests that once-daily dosing will improve compliance.
-
Lives can be saved if complacency over asthma ends, says report
Calls are being made to end the complacency around asthma care so that more is done to save patient lives after the largest ever national study of asthma deaths was published today.
-
Relvar Ellipta launched for asthma and COPD patients
GlaxoSmithKline has officially launched Relvar Ellipta, its once-daily inhaler for asthma and chronic obstructive pulmonary disease patients. A combination of fluticasone furoate and the novel long-acting beta-2 agonist (LABA) vilanterol, the new inhaler can now be ordered in the UK.
Show 10 per page20 per page50 per page
